Expert Care : Access to licensed providers skilled in weight management prescriptions
Medication, supplies, shipping, and follow-up are bundled into the subscription
In comparison, semaglutide (2.4 mg) reduced 14.9% of body weight after 68 weeks in STEP 1 clinical trials
Tirzepatide once weekly for the treatment of obesity, The New England Journal of Medicine (2022) Weight loss outcomes associated with semaglutide treatment for patients with overweight or obesity, JAMA Network (2022) Semaglutide vs tirzepatide for weight loss in adults with overweight or obesity, JAMA Internal Medicine (2024) CVS Health announces it will drop Zepbound and prioritize coverage of Wegovy, Pharmacy Times (2025) Ozempic, DailyMed (2025) Zepbound, DailyMed (2025) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice
Hi Sue, Please contact me directly through website if youd like me to send you more information on this fascinating pathway